ArticleScientific reports2026
Research on the adaptation path of corporate strategy based on the differences in AI governance visions between the Atlantic and China.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Strategic adaptation to divergent AI governance regimes is increasingly central to multinational corporate strategy. Regulatory divergence across the European Union, United States, and China has moved AI governance from a compliance function to a strategy-shaping constraint, yet firm-level adaptation evidence remains disproportionately conceptual and fragmented by single-jurisdiction perspectives. Empirically specifying how multinational firms operationalise cross-regime alignment through changes in deployment architecture, compliance routines, and external signaling remains necessary to support theory-building on strategic adaptation under regulatory fragmentation. To address this empirical gap, the study identifies and quantifies the mechanisms by which multinational firms restructure AI deployment, compliance, and communication in response to fragmented AI governance regimes across the European Union, United States, and China. A comparative multi-case dataset of 12 multinational firms (4 tri-jurisdictional, 4 Atlantic, 4 China-primary) was analyzed, including 48 executive and technical informants and 500 coded adaptation events. This design enables cross-jurisdiction, cross-sector comparison of adaptation intensity and configuration, producing a replicable evidence base for theory-building on how governance exposure and organisational AI maturity jointly shape strategic adaptation pathways. Path-specific composite indices for bifurcation, modularity, ethical signaling, and compartmentalization were quantified using validated scales. Regression models and moderation analyses were performed in R (R Computing, Austria) to examine associations between governance exposure, AI maturity, and adaptation intensity. Tri-jurisdictional firms had larger workforces (5,380 ± 1,245) and higher annual revenues (2,310.4 ± 450.2 million USD) than other groups. Bifurcation scores were highest in the EU (0.84 ± 0.06), while modularity peaked in multinational corporations (0.86 ± 0.04). Ethical signaling intensity was greatest in tech firms (0.82 ± 0.04), and compartmentalization scores were highest for tri-jurisdictional organizations (0.82 ± 0.05). Regression showed governance exposure significantly predicted all adaptation indices (β = 0.35-0.47, R² = 0.29-0.41, all p ≤ 0.004), with AI maturity moderating these effects (p ≤ 0.035). These results clarify why divergent AI governance regimes generate systematically different adaptation profiles, and they provide an empirically grounded basis for aligning corporate strategy, internal controls, and external communication with evolving regulatory and standard-setting expectations across jurisdictions. Firms with higher governance exposure and AI maturity exhibit more advanced, multi-dimensional adaptation across regulatory environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.